Voltaren® 75mg/3ml Ampoules

Voltaren 75mg/3ml ampoules

Indication

Voltaren® 75mg/3ml ampoules contains the sodium salt of diclofenac, a non-steroidal agent with pronounced antirheumatic, anti-inflammatory, analgesic and antipyretic activity¹

In post-traumatic and post-operative inflammatory conditions, Voltaren® rapidly relieves both spontaneous pain and pain on movement, and reduces inflammatory swelling and wound oedema²

Dosage

The dose is generally one 75 mg ampoule daily¹

In severe cases (e.g., colic),the daily dose canexceptionally be increased to two 75 mgampoules, separated by an interval of a fewhours (one into each buttock}.¹

Efficacy

During postoperative period, Patients who achieved pain relief in the Voltaren® IM (n = 55) were significantly more than those who did not achieve pain relief ( n = 5 ; p < 0.05 ).²

Pain during postoperative period (60 minutes) in the Voltaren® IM group²

Study Design

Pharmacokinetics

Peak Plasma Concentrations are reached after about 20 minutes.¹

Time required by Voltaren® IM injection to reach mean peak plasma concertation¹

Diclofenac should therefore not be used by women who are breast-feeding.If treatment is essential, the infant should be switched to bottle feeding¹

For Voltaren® Amp. Abbreviated prescribing information

PDF

References

Voltaren®ampoules Egyptian drug authority leaflet approval date. Approved on 10/02/2025
Al-Waili NS. Efficacy and safety of repeated postoperative administration of intramuscular diclofenac sodium in the treatment of post-cesarean section pain: a double-blind study. Archives of Medical Research. 2001 Mar 1;32(2):148-54

Approved by Egyptian Drug Authority: HF0082OA4731/092025. Invalidation date: 01/09/2027.
Kindly report any violated online promotional, educational and awareness material not having this message to The General administration for Regulation of Marketing & Advertising Materials at: www.edaegypt.gov.eg